Cibus, Inc. (CBUS)
NASDAQ: CBUS · Real-Time Price · USD
1.870
-0.060 (-3.11%)
At close: Aug 6, 2026, 4:00 PM EDT
1.870
0.00 (0.00%)
Pre-market: Aug 7, 2026, 4:48 AM EDT
Cibus Market Cap
Cibus has a market cap or net worth of $142.74 million as of August 7, 2026. Its market cap has increased by 167.81% in one year.
Market Cap
142.74M
Enterprise Value
388.57M
1-Year Change
167.81%
Ranking
Category
Stock Price
$1.87
ChartMarket Cap Chart
Since July 20, 2017, Cibus's market cap has decreased from $288.70M to $142.74M, a decrease of -50.56%. That is a compound annual growth rate of -7.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 142.70M | 51.01% |
| Dec 31, 2025 | 94.50M | 14.96% |
| Dec 31, 2024 | 82.20M | -80.39% |
| Dec 29, 2023 | 419.20M | 5,722.22% |
| Dec 30, 2022 | 7.20M | -91.22% |
| Dec 31, 2021 | 82.00M | -47.57% |
| Dec 31, 2020 | 156.40M | -32.29% |
| Dec 31, 2019 | 231.00M | -31.54% |
| Dec 31, 2018 | 337.40M | -44.70% |
| Dec 29, 2017 | 610.10M | 111.33% |
| Jul 20, 2017 | 288.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| YD Bio | 158.22M |
| Nkarta | 157.40M |
| Milestone Pharmaceuticals | 155.78M |
| Molecular Partners AG | 152.39M |
| Jyong Biotech | 152.18M |
| Indaptus Therapeutics | 150.61M |
| Canton Strategic Holdings | 146.53M |
| Unicycive Therapeutics | 143.27M |